Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. (2008)
Attributed to:
Genetic Engineering of T-cells for Adoptive Immunotherapy of Chronic Lymphocytic Leukemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.CAN-08-0153
PubMed Identifier: 18829564
Publication URI: http://europepmc.org/abstract/MED/18829564
Type: Journal Article/Review
Volume: 68
Parent Publication: Cancer research
Issue: 19
ISSN: 0008-5472